Navigation Links
The Outlook for Pharmaceuticals in North East Asia
Date:11/15/2011

and Novartis. A number of multinational companies are actively seeking to expand their operations in Japan, notably Pfizer, GlaxoSmithKline, Novartis and Bristol-Myers Squibb.

SOUTH KOREA

The implementation of the EU-Korea Free Trade Agreement (FTA) will provide EU companies with better access to the South Korean pharmaceutical market by paving the way for elimination of tariffs on EU pharmaceutical exports to the country. The volume and value of EU pharmaceutical exports are expected to increase with the implementation of EU-Korea FTA, posing a potential threat to US pharmaceutical exporters. The EU-Korea FTA also stipulates that South Korean authorities will be required to align their practices with international standards through an improved regulatory environment. In particular, the EU-Korea FTA will aim to ensure the strengthening of transparency in drug pricing decisions.

TAIWAN

IPR is improving, although there still remain concerns over patent linkage and the data protection of pharmaceuticals in Taiwan. In January 2009, the USTR removed Taiwan from its Special 301 Watch List of countries. However, in the USTR's latest Special 301 Report for 2011, the USA remains concerned with the policies of Taiwan, on issues related to innovation in the pharmaceutical sector and other aspects of healthcare goods and services. Attempts are being made to improve the compatibility of Taiwanese IP with other countries, and Taiwan has signed an IP agreement with China that means that IP is recognised as valid in both countries, even if it is filed only in one.

Use these original and insightful reports to...

* Assess future market values with our unique and regularly reviewed independent 5-year market forecasts.

* Track the latest developments with the news service that is included for every country.

* Understand the critical issues and drivers which are shaping the market.

* Evaluate the environment for bran
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
2. July 2009 Mayo Clinic Health Letter Highlights a Positive Outlook, Bells Palsy and Heart Valve Repair
3. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
4. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
5. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
6. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
7. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
8. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
9. Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
10. Stryker Updates Expected 2009 Results and Provides 2010 Outlook
11. Beckman Coulter Affirms 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... the development and commercialization of innovative therapies for the ... PDUFA date for Zalviso remains July 27, 2014.  ... online stating the Food and Drug Administration (FDA) had ... been no notification to the company from the FDA ...
(Date:7/24/2014)... HILDEN , Germany , and ... , Exclusive global ... assays for SF3B1 mutations, including next-generation sequencing (NGS) gene ... gene, to be targeted by new test, indicate favorable ... myelodysplastic syndromes  QIAGEN sees potential for developing ...
(Date:7/24/2014)... -- Amgen (NASDAQ: AMGN ) today announced that ... July 29, 2014, after the close of the U.S. financial ... with the investment community at 2 p.m. PT. Participating in ... , chairman and chief executive officer, and other members of ... conference call will be simultaneously broadcast over the Internet and ...
Breaking Medicine Technology:AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 2QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 3QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 4QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline 5Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
...  The advanced functionality of Elekta,s family of digital ... coordination. Elekta,s latest control system, Integrity™ R1.1, meets ... of MLC interdigitation for exceptional field shaping, and ... radiation dose. Integrity ...
... Inc. (NASDAQ: VSCP ), a leading provider of ... Markin, the company,s president and chief executive officer, will be ... CEO & Investor Conference at the Waldorf Astoria in New ... 13, 2012 at 4:30 PM ET. A live ...
Cached Medicine Technology:Sixth Generation Elekta Digital Control System Boosts Radiation Therapy System Speed and Performance 2VirtualScopics to Present at the 14th Annual BIO CEO & Investor Conference 2
(Date:7/26/2014)... According to the Banish My Bumps ... comprehensive guide that covers detailed instructions on how to ... need of any medication. , Vkool reveals in ... safe remedies for relieving symptoms of keratosis pilaris quickly. ...     How to treat children's keratosis pilaris , ...
(Date:7/25/2014)... Staffordshire, UK (PRWEB) July 26, 2014 ... a variety of dental services including general dentistry, clear ... practice opening in September this year in Derby. The ... is at the HollyBrook Medical Centre in Littleover, Derby. ... the new practice. , The new dental practice, which ...
(Date:7/25/2014)... In recent years, men have become more ... the symptoms associated with age-related testosterone decline. Amid concerns about ... new case study from Renew Man helps to ... using bioidentical hormones. , The case study centers around ... found himself beginning to feel the effects of age-related hormonal ...
(Date:7/25/2014)... July 25, 2014 As reported by the ... War On Heroin (7/20), police in Salem, MA as ... down on the recent heroin epidemic that has taken many ... on one heroin-related overdose case in which police were able ... victim's cell phone. By pretending to be the victim and ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Seniors are more easily distracted ... new study finds. "Almost any type of memory ... age of 25 on," study co-author Randi Martin, professor ... news release. However, Martin said, this study shows ... in older adults compared with younger adults. The ...
Breaking Medicine News(10 mins):Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 2Health News:Banish My Bumps Pdf Review Exposes Angela Steinberg's Keratosis Pilaris Treatment Plan – Vkool.com 3Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Multiple States Crack Down on Heroin Epidemic 2Health News:Distractions Seem More Troublesome With Age 2
... made from some of the same parts used in ... way to measure the growth and drug susceptibility of ... The new biosensor promises to speed treatment of ... Smalley Distinguished University Professor of Chemistry, Physics and Applied ...
... Thea Friedman, M.D., associate scientist and director of ... at Hackensack University Medical Center was recently awarded a ... RO1 research grant to improve allogeneic blood and marrow ... $2 million in funding over the next five years. ...
... a successful Phase 1 study for safety, researchers at ... today announced the beginning of a Phase 2 clinical ... they developed to prevent hepatitis C virus (HCV) ... The first patients were enrolled in the study in ...
... - A recent study by Merikangas and colleagues published ... of the American Academy of Child and Adolescent Psychiatry ... are affected with severely impairing mental disorders ever receive ... that approximately one third of adolescents with any mental ...
... researchers have used a type of brain scanning, known as ... in blood flow in the brain and to correlate this ... data, which could improve is reported in the International ... have known since the 1890s that changes in blood flow ...
... risk factors for breast cancer are well studied and documented. ... period, late onset of menopause and a family history of ... However, neither an individual woman nor medicine can influence ... menopause starts - these are risk factors on which we ...
Cached Medicine News:Health News:See how they grow: Monitoring single bacteria without a microscope 2Health News:See how they grow: Monitoring single bacteria without a microscope 3Health News:Oncology basic research director at John Theurer Cancer Center continues transplantation research 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 2Health News:First liver transplant patients receive experimental drug to prevent hepatitis C infection 3Health News:Adolescents with severe mental disorders have never received treatment 2Health News:Functional boost for magnetic resonance imaging 2Health News:Scientists identify avoidable breast cancer risk factors 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: